Physician profile
Eric K Wellmeyer
NPI 1396766846
$868.21
in general payments reported to CMS, 2019-2025
10 companies · $295 in 2025
The $295 reported for 2025 was more than what 86% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.31 · 2020: $22.38 · 2021: $121 · 2022: $238 · 2024: $119 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363 · Education: $51.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.10 |
| Education | $51.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $173.28 | 2022 | |
| Octapharma USA, INC. | $123.72 | 2025 | Fibryga |
| Acacia Pharma INC | $121.22 | 2021 | |
| Heron Therapeutics, INC. | $120.35 | 2025 | Zynrelef, Aponvie |
| Pacira Pharmaceuticals Incorporated | $119.03 | 2024 | Exparel |
| Vyaire Medical, INC. | $64.52 | 2022 | |
| Ethicon US, LLC | $58.82 | 2019 | |
| Merck Sharp & Dohme LLC | $51.40 | 2025 | Bridion |
| Sun Pharmaceutical Industries INC. | $22.38 | 2020 | |
| Avanos Medical | $13.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wellmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.